Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Eukaryotic translation initiation factor 2-alpha kinase (EIF2AK) family members EIF2AK1 (HRI), EIF2AK2 (PKR), and EIF2AK4 (GCN2) are essential regulators of the Integrated Stress Response (ISR) (NIH, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116144/; Frontiers in Cell and Developmental Biology, https://www.frontiersin.org/articles/10.3389/fcell.2020.00167). These kinases function as sensors for distinct cellular stressors: EIF2AK1 responds to heme deficiency and oxidative stress, EIF2AK2 is activated by viral double-stranded RNA, and EIF2AK4 senses amino acid starvation via uncharged tRNAs (Reactome, https://reactome.org/content/detail/R-HSA-380953; Wikipedia, https://en.wikipedia.org/wiki/EIF2AK4). Upon activation, they phosphorylate the alpha subunit of eukaryotic translation initiation factor 2 (eIF2α) at Ser51, which attenuates global protein synthesis while selectively enhancing the translation of stress-adaptive mRNAs like ATF4 (UniProt, https://www.uniprot.org/uniprot/Q9BQI3; Abcam, https://www.abcam.com/pathways/integrated-stress-response). This pathway is frequently co-opted by cancer cells to survive metabolic stress and is implicated in the progression of neurodegenerative diseases, viral infections, and pulmonary veno-occlusive disease (GeneCards, https://www.genecards.org/cgi-bin/carddisp.pl?gene=EIF2AK4; BioRxiv, https://www.biorxiv.org/content/10.1101/2024.04.23.590745v1). Pharmacological modulators, including small-molecule inhibitors like GCN2iB and PKR inhibitors, are being developed to either disrupt tumor adaptation or restore translational homeostasis in chronic disease states (GlobalData, https://www.pharmaceutical-technology.com/data-insights/eif-2-alpha-kinase-gcn2-eif2ak4-pipeline-analysis-and-market-forecast/).
Inhibition of eIF2α phosphorylation to modulate the integrated stress response (ISR), thereby restoring global protein synthesis or inducing apoptosis in stressed cells (Frontiers in Oncology, https://www.frontiersin.org/articles/10.3389/fonc.2021.654398; Nature Communications, https://www.nature.com/articles/s41467-023-40823-8).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 2-alpha kinase family (EIF2AK1, EIF2AK2, EIF2AK4) (EIF2AK family).